Margaret W.

Margaret (Chia-Ying) W. is a Clinical Development Director and scientist with a background in pharmacy, specializing in neuroscience, psychiatry, hematology, and oncology. With experience in both pre-clinical and clinical research, they have managed over 100 clinical trials across various disease groups and developed clinical protocols, achieving significant regulatory milestones including an accelerated NDA approval from the FDA. Margaret's earlier roles included positions at prestigious institutions such as Harvard Medical School, Massachusetts General Hospital, and AstraZeneca, where they received the “Rising Leader 2022” award for leadership. They currently pursue a PhD while contributing as a podcaster in the biotech field.